Neurodegenerative diseases such as Alzheimer's or Parkinson's are associated with the prionlike propagation and aggregation of toxic proteins. A long standing hypothesis that amyloid-beta drives Alzheimer's disease has proven the subject of contemporary controversy; leading to new research in both the role of tau protein and its interaction with amyloid-beta. Conversely, recent work in mathematical modelling has demonstrated the relevance of nonlinear reaction-diffusion type equations to capture essential features of the disease. Such approaches have been further simplified, to network-based models, and offer researchers a powerful set of computationally tractable tools with which to investigate neurodegenerative disease dynamics.Here, we propose a novel, coupled network-based model for a two-protein system that includes an enzymatic interaction term alongside a simple model of aggregate transneuronal damage. We apply this model to test the possible interactions between tau proteins and amyloidbeta and study the complex coupled behaviour between toxic protein clearance and proteopathic propagation. This analysis reveals that amyloid-beta and tau proteins conspire with each other to enhance the nucleation and propagation of different diseases, thus shedding new light on the importance of protein clearance and protein interaction mechanisms in prion-like models of neurodegenerative disease. dominated the search for cures and treatments [5,6]. According to this hypothesis, an imbalance between production and clearance of Aβ42 and other Aβ peptides is not only an early indicator of the disease but the causing factor for its initiation, progression, and pathogenesis [7]. However, the repeated failures of large clinical trials focussing on the reduction of Aβ plaques has led many researchers to question the amyloid hypothesis and argue for the possible importance of other mechanisms.The obvious alternative is τ P that are usually considered secondary agents in the disease despite the fact that (1) other τ P-related diseases (tauopathies), such as frontotemporal lobar degeneration, are mostly dominated by τ P spreading [8];(2) brain atrophy in AD is directly correlated with large concentrations of NFT [9, 10]; (3) τ P distribution determines disease staging [11]; (4) lowering τ P levels prevent neuronal loss [12]; (5) τ P reduces neural activity and is the main factor associated with cognitive decline [13]. These findings may explain the relative lack of clinical improvements after Aβ suppression and the debate between the relative importance of Aβ proteopathy and τ P tauopathy in AD [14]. Furthermore, the similarity in mechanism and progression between prion diseases [15] and classical neurodegenerative diseases led to the formulation of the ''prion-like hypothesis" [16,17,18,19,20,21] stating that all these protein-related degenerative diseases are characterized by the progressive spreading and autocatalytic amplification of abnormal proteinaceous assemblies through axonal pathways [22].Since so many cellular mechanis...